
The Pharmacy Council of Nigeria (PCN) has challenged the Chairman of the Kano State Multi-Agency Taskforce on Drug Abuse and Illicit Trafficking, Muhuyi Magaji Rimin Gado, to substantiate allegations that the agency is shielding drug dealers and facilitating the distribution of illicit substances in Kano State.
Describing the allegations as baseless, the PCN, in a rebuttal signed by Pharm. Hasiya Ladan, Consultant Pharmacist at its Kano State Office, urged Gado to provide evidence to support his claims of misconduct against some of its personnel, stressing that it takes allegations of staff misconduct seriously.
At a press conference , Gado had questioned the circumstances surrounding the issuance of import licences to pharmaceutical companies dealing in pregabalin, particularly following its rescheduling as a controlled drug by the National Agency for Food and Drug Administration and Control (NAFDAC) on September 14, 2026.
He further alleged that the PCN “facilitated these unlawful activities by registering No. 10 Apple Avenue, a purely residential area to serve as a concealed outlet that has been used contrary to the provision of the Land Use Act, and which has been used as a means for distribution of this product to our streets. By doing so, the PCN has compromised the entire rationale of CWC which they advocate.”
The task force chairman also claimed that “Task force investigation reveals that some staff of the PCN engaged deeply in these types of clandestine business which explains why they are over protective and always want to be exclusive…”
He further alleged that the PCN had fewer than 20 staff members in Kano but continued to insist that it had exclusive powers to seal pharmaceutical premises, even when wrongdoing was uncovered.
Responding to the allegations, the PCN said its exclusive regulatory authority over pharmaceutical premises had been established by the Constitution and affirmed by the Supreme Court in Pharmacists Board of Nigeria v. Franklin Adegbesote (1986) 5 NWLR (Pt. 44) 707, SC 68/1986. It also cited a Federal High Court judgment in Kano in Suit No. FHC/KN/CS/152/2023 (16 February 2024), National Assembly resolutions of 2018 and 2025, and a letter dated March 28, 2001, by the then Attorney General of the Federation and Minister of Justice, Chief Bola Ige, SAN, to the Attorney General/Commissioner for Justice, Rivers State.
“This exclusive right is not in doubt, as the Chairman, being a lawyer, should be familiar with some of the institutions and instruments mentioned here,” the Council stated.
Ladan also dismissed Gado’s claims about the PCN’s alleged lack of regulatory capacity, describing them as evidence of ignorance of the Council’s regulatory framework.
“For emphasis, the regulatory framework or structure for recommendation for approval and licensing of premises is robust and is well established in the 36 states of the Federation and the FCT, with appropriate legal framework,” she stated.
She explained that the PCN had established two committees in every state: the Pharmaceutical Inspection Committee (PIC) and the Patent and Proprietary Medicines Vendors Licence Committee (PPMVLC). Both committees are chaired by the Directors of Pharmaceutical Services (DPSs) in the respective State Ministries of Health, who represent the interests of state governments.
According to her, each PSN State Chairman serves as vice-chairman of the committees, while PCN officers and other experienced and credible pharmacists appointed within the states serve as inspectors.
“It is this structure that inspects and recommends for approval all facilities for licensure. For emphasis, the PCN Officer-in-Charge only serves as Secretary to the two committees and also provides secretariat services,” she explained.
Ladan maintained that the Council’s ability to discharge its regulatory responsibilities was not determined by the number of its personnel in Kano, noting that it could mobilise the required human resources whenever necessary.
She added that the PCN’s regulatory capacity had been affirmed by the World Health Organisation (WHO) during its Global Benchmarking of Nigeria for Maturity Level 3, noting that PCN and NAFDAC were the only national regulatory authorities in Africa to have achieved and retained the global ranking.
On the issuance of import licences and product permits, the Council clarified that while the PCN is responsible for issuing import licences to importing companies, NAFDAC is responsible for issuing product permits specifying the categories and quantities of products to be imported.
“Except there is evidence of illegal distribution of the drug from the said premises, the Chairman cannot allege any wrongdoing,” Ladan stated.
Addressing the allegation that the PCN had registered a pharmaceutical outlet in a residential area in violation of the Land Use Act, the Council faulted Gado for failing to identify the specific provisions of the Act allegedly breached.
It explained that its Pharmaceutical Premises Location, Inspection, Structure, Monitoring and Enforcement Regulations, 2022 stipulate the requirements for the registration and location of pharmaceutical premises.
“Whether a facility allocated for residential purposes can be used for the sale of medicines or any pharmaceutical product is not for the Pharmacy Council of Nigeria to decide. This is not one of the issues that is taken into consideration in determining an application for location approval.
“The law does not restrict or prohibit the registration of pharmaceutical premises in residential areas. Therefore, both residential and commercial areas are, by the Act, eligible for registration, provided they meet other requirements of the law,” Ladan stated.





